Drug Abuse and Psychosis: New Insights into Drug-induced Psychosis.
- Author:
Suji HAM
1
;
Tae Kyoo KIM
;
Sooyoung CHUNG
;
Heh In IM
Author Information
- Publication Type:Review
- Keywords: drug abuse; psychosis; drug induced psychosis; schizophrenia; animal model
- MeSH: Amphetamine; Anhedonia; Classification; Executive Function; Hallucinations; Humans; Lysergic Acid Diethylamide; Models, Animal; Psychotic Disorders*; Schizophrenia; Scopolamine Hydrobromide; Substance-Related Disorders*
- From:Experimental Neurobiology 2017;26(1):11-24
- CountryRepublic of Korea
- Language:English
- Abstract: Addictive drug use or prescribed medicine abuse can cause psychosis. Some representative symptoms frequently elicited by patients with psychosis are hallucination, anhedonia, and disrupted executive functions. These psychoses are categorized into three classifications of symptoms: positive, negative, and cognitive. The symptoms of DIP are not different from the symptoms of schizophrenia, and it is difficult to distinguish between them. Due to this ambiguity of distinction between the DIP and schizophrenia, the DIP animal model has been frequently used as the schizophrenia animal model. However, although the symptoms may be the same, its causes are clearly different in that DIP is acquired and schizophrenia is heritable. Therefore, in this review, we cover several DIP models such as of amphetamine, PCP/ketamine, scopolamine, and LSD, and then we also address three schizophrenia models through a genetic approach with a new perspective that distinguishes DIP from schizophrenia.
